View drug registration information details.
Items | Registration information |
ID | 499 |
No | 499 |
Brand Name | ESOWAN 40 |
Ingredients | ESOMEPRAZOLE TRIHYDRATE USP EQ.TO ESOMEPRAZOLE 40 MG |
Dosage Form | TABLET |
Primary Packaging | ALU-ALU BLISTER |
Storage | STORE IN DRY PLACE BELOE 30 C |
Shelf Life | 30 MONTHS |
Pack Size | BOX OF 10 X 10'S |
Dispensing Category | Prescription only |
ATC Classification | A02BC05 |
Pharmaceutical Class | PPI |
Indications | TREATMENT OF EROSIVE REFLUX ESOPHAGITIS, LONG TERM MANAGEMENT OF PATIENTS WITH HEALED ESOPHAGITIS TO PREVENT RELAPSE, SYMPTOMATIC TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE |
Contraindications | HYPERSENSITIVITY, USED CONCOMITANTLY WITH NELFINAVIR |
Side Effects | PERIPHERAL OEDEMA, INSOMNIA, HEADACHE, DIZZINESS, PARAESTHESIA, SOMNOLENCE, VERTIGO, ABDOMINAL PAIN, CONSTIPATION |
Unit Price | |
EDL |
Yes |
Description | WHITE TO OFF WHITE COLOR, ROUND SHAPED, BICONVEX, ENTERIC COATED TABLETS |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | ARGON REMEDIES PVT LTD |
Country | INDIA |
Import Registration No | 2/SC/P OF 1987 (FORM 28) |
Import Registration Date | 2020-01-13 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2022-07-22 |
FDD Registration No | 02 I 5692/24 |
FDD Registration Date | 2024-02-26 |
Expiry Date | 2027-02-25 |
Back to drug list
|